These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2201940)

  • 1. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia.
    Van Marter LJ; Leviton A; Kuban KC; Pagano M; Allred EN
    Pediatrics; 1990 Sep; 86(3):331-6. PubMed ID: 2201940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation.
    Smith LM; Qureshi N; Chao CR
    J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal glucocorticoid therapy for prevention of bronchopulmonary dysplasia: routes of administration compared.
    Cole CH
    Semin Neonatol; 2001 Aug; 6(4):343-50. PubMed ID: 11972435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
    J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants.
    Sehdev HM; Abbasi S; Robertson P; Fisher L; Marchiano DA; Gerdes JS; Ludmir J
    Am J Obstet Gynecol; 2004 Oct; 191(4):1409-13. PubMed ID: 15507974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia.
    Hansen AR; Barnés CM; Folkman J; McElrath TF
    J Pediatr; 2010 Apr; 156(4):532-6. PubMed ID: 20004912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants.
    Baud O; Foix-L'Helias L; Kaminski M; Audibert F; Jarreau PH; Papiernik E; Huon C; Lepercq J; Dehan M; Lacaze-Masmonteil T
    N Engl J Med; 1999 Oct; 341(16):1190-6. PubMed ID: 10519896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland].
    Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
    Feldman DM; Carbone J; Belden L; Borgida AF; Herson V
    Am J Obstet Gynecol; 2007 Sep; 197(3):284.e1-4. PubMed ID: 17826422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perinatal glucocorticosteroid therapy: time for reconsideration].
    Groneck P
    Z Geburtshilfe Neonatol; 2001; 205(6):231-5. PubMed ID: 11745009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life.
    Cunha GS; Mezzacappa-Filho F; Ribeiro JD
    J Trop Pediatr; 2005 Dec; 51(6):334-40. PubMed ID: 15927945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intrauterine cocaine exposure on the respiratory status of the very low birth weight infant.
    Hand IL; Noble L; McVeigh TJ; Kim M; Yoon JJ
    J Perinatol; 2001 Sep; 21(6):372-5. PubMed ID: 11593371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia?
    Antonucci R; Contu P; Porcella A; Atzeni C; Chiappe S
    J Perinat Med; 2004; 32(3):272-7. PubMed ID: 15188804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.
    Kewitz G; Wudel S; Hopp H; Hopfenmüller W; Vogel M; Roots I
    J Perinat Med; 2008; 36(4):359-64. PubMed ID: 18598128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.
    Onland W; van Kaam AH; De Jaegere AP; Offringa M
    Pediatrics; 2010 Oct; 126(4):e954-64. PubMed ID: 20837588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
    Schmidt B; Roberts R; Millar D; Kirpalani H
    Neonatology; 2008; 93(4):284-7. PubMed ID: 18525211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.